Type Public (Euronext: ERF) Founded 1987 Website www.eurofins.com CEO Gilles G. Martin (2012–) Founder Gilles G. Martin | Industry Laboratory analysis Number of employees 23,000 (2016) Headquarters Luxembourg Revenue 2.24 billion EUR (2015) | |
 | ||
Stock price ERF (EPA) € 404.75 +0.45 (+0.11%)9 Mar, 2:31 PM GMT+1 - Disclaimer | ||
Gilles martin ceo of eurofins scientific on transforming bioanalytical testing
Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins employs more than 20,000 employees across around 200 sites in 39 countries and has about EUR 2.24 billion annual revenues (2015).
Contents
- Gilles martin ceo of eurofins scientific on transforming bioanalytical testing
- Recent news
- Product authentication
- References
The Eurofins Group offers a portfolio of over 130,000 reliable analytical methods for characterizing the safety, identity, purity, composition, authenticity and origin of products and biological substances. Through research and development, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical sciences.
Eurofins pursued an aggressive strategy of expansion, buying more than eighty competitors worldwide since it was founded. Notable examples include the acquisition in 2005 of the German company MWG-Biotech and in 2011 of the US company Lancaster Laboratories the latter being acquired for 150 million euros.
Recent news
In May 2015, Eurofins acquired QC Laboratories in the US and Experchems in Canada as part of its American expansion strategy. In June 2015, Eurofins announced the acquisition of Biomnis in France for 220 million euros.
Product authentication
The company has developed an exclusive method of food analysis, testing and authentication that has thwarted the counterfeiting of food goods, and also cigars. The company's testing can also detect food contaminants.